MUIR GLENN P
Reporting owner on Forms 3, 4 and 5, CIK 1181190.
MUIR GLENN P reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-11-20.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| STIM · Neuronetics, Inc.CIK 1227636 | director | 2 | 2026-11-19 |
| CTKB · Cytek Biosciences, Inc.CIK 1831915 | director | 1 | 2026-11-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTKB · Cytek Biosciences, Inc.Common Stock | 2026-11-18 | M exercised | +4,629 | 7,715 | Form 4 | |
| CTKB · Cytek Biosciences, Inc.Restricted Stock Units, derivative | 2026-11-18 | M exercised | -4,629 | $0 | 47,840 | Form 4 |
| STIM · Neuronetics, Inc.Common Stock | 2026-11-16 | A granted | +175,000 | $1.31 | 576,816 | Form 4/A |
| STIM · Neuronetics, Inc.Common Stock, superseded by an amendment | 2026-11-16 | A granted | +175,000 | $1.31 | 576,816 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001181190-26-000008 | Cytek Biosciences, Inc. | 2026-11-20 | ||
| Form 4/A 0001193125-26-467855 | Neuronetics, Inc. | 2026-11-19 | ||
| Form 4 0001193125-26-467079 | Neuronetics, Inc. | 2026-11-18 |